Welcome!
Home PhillipCapital
Broker's Calls
DBS holds $100 bil market cap for second day; analysts mixed on 1QFY2024 results
The analysts' target prices range from $35.90 to $40.70.
May 06, 2024
Broker's Calls
RHB upgrades Suntec REIT to ‘buy’ on strong operational metrics; analysts up TPs on forward estimates
Analysts from CGS-CIMB, DBS, Maybank and OCBC have kept their "hold" calls while Citi has kept its "sell" rating.
January 25, 2024
Fintech
Alta partners PhillipCapital to offer liquidity programme for Income Insurance shares
It is the largest listing of a non-listed company on a private securities exchange.
January 12, 2024
Singapore economy
Betting on a Singapore swing
REITs are expected to be a favourite with brokerages this year on the back of anticipated rate cuts.
January 11, 2024
Broker's Calls
Brokers' Digest: Parkway Life REIT, Cromwell European REIT, United Hampshire US REIT, Raffles Medical, Yoma Strategic
See what the analysts have to say this week.
January 11, 2024
Investing 101
Should investors invest into these STI-tracked ETFs? PhillipCapital takes a closer look
The team estimates that the implied value for Nikko AM Singapore STI ETF is $3.69 and $3.73 for the SPDR Straits Times Index ETF.
January 10, 2024
Broker's Calls
PhillipCapital highlights Yoma’s response to challenging macro environment in an unrated report
Yoma has been de-gearing its balance sheet, disposing its non-core assets, localising costs as well as rebalancing its headcount.
January 08, 2024
Broker's Calls
PhillipCapital maintains 'buy' for Elite Commercial REIT after news of GBP28mil raise through preferential offering
Analyst Liu Miaomiao has factored in transitions into calculations, maintains forecast with target price of 0.36 GBP pence.
December 20, 2023
Broker's Calls
Hospitality and retail S-REITs preferred amid tailwind from expectations of rate cuts: PhillipCapital
Analyst Darren Chan says now is an “opportune time” for investors to reposition themselves into the sector.
December 19, 2023
Broker's Calls
PhillipCapital and CGS-CIMB analysts lower target price for NYSE-listed TDCX, following drag from largest customer Meta
PhillipCapital and CGS-CIMB have target prices of US$8.60 and US$6.20, and “buy” and “hold” calls respectively.
November 29, 2023